PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients
AbstractMultiple myeloma (MM) is a hematological neoplasm characterized by the clonal proliferation of malignant plasma cells in the bone marrow. MM results in diffuse or focal bone infiltration and extramedullary lesions. Over the past two decades, advances have been made with regard to the diagnosis, staging, treatment, and imaging of MM. Computed tomography (CT) and magnetic resonance imaging (MRI) are currently recommended as the most effective imaging modalities at diagnostic. Yet, recent data from the literature suggest that positron emission tomography combined with computed tomography (PET/CT) using 18F-deoxyglucose (FDG) is a promising technique for initial staging and therapeutic monitoring in this pathology. This paper reviews the recent advances as well as the potential place of a more specific radiopharmaceutical in MM. View Full-Text
Share & Cite This Article
Bailly, C.; Leforestier, R.; Jamet, B.; Carlier, T.; Bourgeois, M.; Guérard, F.; Touzeau, C.; Moreau, P.; Chérel, M.; Kraeber-Bodéré, F.; Bodet-Milin, C. PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients. Int. J. Mol. Sci. 2017, 18, 445.
Bailly C, Leforestier R, Jamet B, Carlier T, Bourgeois M, Guérard F, Touzeau C, Moreau P, Chérel M, Kraeber-Bodéré F, Bodet-Milin C. PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients. International Journal of Molecular Sciences. 2017; 18(2):445.Chicago/Turabian Style
Bailly, Clément; Leforestier, Rodolphe; Jamet, Bastien; Carlier, Thomas; Bourgeois, Mickael; Guérard, François; Touzeau, Cyrille; Moreau, Philippe; Chérel, Michel; Kraeber-Bodéré, Françoise; Bodet-Milin, Caroline. 2017. "PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients." Int. J. Mol. Sci. 18, no. 2: 445.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.